(PACB) Pacific Biosciences of - Performance -28.6% in 12m
Compare PACB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-63.61%
#38 in Group
Rel. Strength
17.06%
#6600 in Universe
Total Return 12m
-28.57%
#32 in Group
Total Return 5y
-66.20%
#34 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -0.17
10th Percentile in Group
FCF Yield -34.99%
(?) Percentile in Group
12m Total Return: PACB (-28.6%) vs XLV (-4.1%)
5y Drawdown (Underwater) Chart
Top Performers in Life Sciences Tools & Services
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| A NYSE Agilent Technologies |
9.48% | -23.3% | 38.3% | 24.9 | 19.3 | 1.76 | 60.8% | 7.8% |
| RVTY NYSE Revvity |
1.28% | -9.43% | 0.59% | 38.4 | 19.2 | 0.67 | -50.1% | -36.8% |
| QGEN NYSE Qiagen |
8.63% | -1.88% | -1.95% | 113 | 18.1 | 0.99 | -64.4% | -7.5% |
| SHC NASDAQ Sotera Health |
35% | 18% | -47.3% | 138 | 20.2 | 1.68 | -54.5% | -23.6% |
Performance Comparison: PACB vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for PACB
| Total Return (including Dividends) | PACB | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 0.00% | 0.87% | 13.81% |
| 3 Months | -9.77% | -7.96% | -6.30% |
| 12 Months | -28.57% | -4.06% | 10.65% |
| 5 Years | -66.20% | 43.49% | 107.77% |
| Trend Score (consistency of price movement) | PACB | XLV | S&P 500 |
| 1 Month | -75.4% | -8.1% | 83% |
| 3 Months | -81.7% | -75.3% | -75.3% |
| 12 Months | -43.5% | -28.8% | 50.1% |
| 5 Years | -64.9% | 89.7% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #35 | -0.86% | -12.1% |
| 3 Month | #24 | -1.97% | -3.71% |
| 12 Month | #32 | -25.6% | -35.4% |
| 5 Years | #34 | -76.4% | -83.7% |
FAQs
Does PACB Pacific Biosciences of outperforms the market?
No,
over the last 12 months PACB made -28.57%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.06%.
Over the last 3 months PACB made -9.77%, while XLV made -7.96%.
Over the last 3 months PACB made -9.77%, while XLV made -7.96%.
Performance Comparison PACB vs Indeces and Sectors
PACB vs. Indices PACB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 6.93% | -13.8% | -42.9% | -39.2% |
| US NASDAQ 100 | QQQ | 6.74% | -17.4% | -43.1% | -40.2% |
| US Dow Jones Industrial 30 | DIA | 6.52% | -9.99% | -42.6% | -36.3% |
| German DAX 40 | DAX | 6.95% | -15.0% | -69.2% | -54.3% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.75% | -11.8% | -43.7% | -35.9% |
| Hongkong Hang Seng | HSI | 3.76% | -19.9% | -51.3% | -42.3% |
| India NIFTY 50 | INDA | 11.9% | -4.84% | -43.3% | -28.4% |
| Brasil Bovespa | EWZ | 5.88% | -17.2% | -51.6% | -20.2% |
PACB vs. Sectors PACB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.29% | -13.4% | -50.0% | -50.1% |
| Consumer Discretionary | XLY | 6.55% | -14.2% | -41.9% | -42.8% |
| Consumer Staples | XLP | 7.79% | -6.59% | -49.8% | -37.7% |
| Energy | XLE | 7.11% | -6.76% | -36.3% | -19.1% |
| Financial | XLF | 5.83% | -13.5% | -50.0% | -51.0% |
| Health Care | XLV | 9.94% | -0.87% | -37.9% | -24.5% |
| Industrial | XLI | 5.24% | -16.8% | -44.3% | -39.6% |
| Materials | XLB | 7.13% | -13.6% | -38.0% | -23.3% |
| Real Estate | XLRE | 8.25% | -11.5% | -43.6% | -44.0% |
| Technology | XLK | 5.85% | -21.2% | -40.0% | -35.7% |
| Utilities | XLU | 6.88% | -9.59% | -50.6% | -46.0% |
| Aerospace & Defense | XAR | 4.95% | -21.2% | -54.4% | -55.9% |
| Biotech | XBI | 13.5% | -11.8% | -22.8% | -16.3% |
| Homebuilder | XHB | 6.46% | -11.5% | -29.7% | -21.0% |
| Retail | XRT | 5.03% | -14.7% | -38.7% | -27.1% |